1. r,f- * 1d"*".. u|"^" 5
NitrnidrebthehdNidL'a| a)
farcanorrj4bn, dd 13)'lheLdnclof'lr individual
b Er* d,iedbr brhemrrrEsera
oqN'i6"mnredod!dtedDDsMrbed'Aorrcd
quriliod pr'edire oldef laro). np aPo t | reun
'Yo!.aDceredsrmroryasumnfqaQPo r,e
$rs !,3 $dher hmp drcyrmrcbj
Drugfticing ls Point of Weakness
ForI'Iedicare, ledicaid, SaF lG
DddcddcanonJulyI rdcnrifiedr6qiptt,n d'uC!1r
amaFr$um orMedrn andM.dicaidabE tr,kdt
mooyonCaprdlllillsheurcedconsnsroindude
rrrudmd abus salee$Jilsh my llied'ure drut 4i'
le 3trdlhtd $vml .rc6 otthepmgratr rhd.an be
lGane.JandRchnqudn.ppelrdownluier.$apre
vi,uslyd,crorlvledtm pmcrmrinbsriryatCMS
whi . Mcdtaid ftn.blss rormanymoredrugs
diar dmsl{cdiurc.Codsao poi.td odrdErbothface
riffi.anl vulnsabilitils whcnit loma rop.e{dpdon
HIPAAAuthorization Formlglatrix
tb canlcanptknceNcFA@ihvhhl d nerct clik the